MainNumber of submissions with electronic datasets reaching mid-cycle review during the monthThese measures have been retired as CDER has created new measures for FY13 which align to their four functional areas of 1) Regulatory Review and Drug Safety, 2) Drug Quality and Compliance, 3) Transparency and Public Outreach, and 4) Regulatory Science Research.Numbercolumn02010Measure was implemented starting April 20102011FY 2011 Total: 932012FY 2012 YTD: 27http://www.fda.gov/AboutFDA/Transparency/track/ucm206444.htmFDA-TRACK CDER DashboardSubNumber of submissions with electronic datasets reaching mid-cycle review during the monthPercent of submissions reaching mid-cycle review during the month that required minimal or no additional data management prior to performing analyses and no requests for additional datasets were made to sponsorPercent01002010Measure was implemented starting April 2010010020112012SubNumber of submissions with electronic datasets reaching mid-cycle review during the monthPercent of submissions reaching mid-cycle review during the month that required additional data management prior to performing analyses, but no requests for additional datasets were made to the sponsorPercent01002010Measure was implemented starting April 2010010020112012SubNumber of submissions with electronic datasets reaching mid-cycle review during the monthPercent of submissions reaching mid-cycle review during the month that required additional data requests to sponsor for adequate analysis datasetsPercent01002010Measure was implemented starting April 2010010020112012